Antimicrobial susceptibility of klebsiella pneumoniae and escherichia coli with extended-spectrum β-lactamase associated genes in hospital Tengku Ampuan Afzan, Kuantan, Pahang

Malaysian Journal of Medical Sciences

Volumn 23, Issue 2, 2016, Pages 14-20

  Mahdi Yahya Mohsen, Saleh ^a   Hamzah, Hairul Aini ^a   Muhammad Imad Al Deen, Mustafa ^a   Baharudin, Roesnita ^b  

^a INTERNATIONAL ISLAMIC UNIVERSITY MALAYSIA   (Malaysia)

^b Hospital Tengku Ampuan Afzan   (Malaysia)

Author keywords

Antimicrobial resistance; Beta Lactamases; Escherichia coli; Hospital; Klebsiella pneumoniae

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; SULTAMICILLIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLACTX M GENE; BLASHV GENE; BLATEM GENE; CONTROLLED STUDY; DISK DIFFUSION; ESCHERICHIA COLI; GENE AMPLIFICATION; HOSPITAL; KLEBSIELLA PNEUMONIAE; MALAYSIA; NONHUMAN; POLYMERASE CHAIN REACTION; SCREENING;

EID: 84959502051     PISSN: 1394195X     EISSN: 21804303     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Carlet J, Jarlier V, Harbarth S, Voss A, Goossens H, Pittet D. Ready for a world without antibiotics ? The Pensières Antibiotic Resistance Call to Action. Antimicrob Resist Infect Control. 2012;1(11). doi: 10.1186/2047-2994-1-11.
2. Kang C, Song J. Antimicrobial Resistance in Asia : Current Epidemiology and Clinical Implications. Clinical Implications. Infect Chemother. 2013;45(1):22–31. doi: 10.3947/ic.2013.45.1.22.
3. Paterson DL. Resistance in gram-negative bacteria: enterobacteriaceae. Am J Med. 2006;119(6 Suppl 1):S20–28.
4. Zhou T, Zhang X, Guo M, Ye J, Lu Y, Bao Q, et al. Phenotypic and molecular characteristics of carbapenem-non-susceptible Enterobacteriaceae from a teaching hospital in Wenzhou, southern China. Jpn J Infect Dis. 2013;66(2):96–102.
5. Rupp ME, Fey PD. Extended spectrum betalactamase (ESBL)-producing Enterobacteriaceae: considerations for diagnosis, prevention and drug treatment. Drugs. 2003;63(4):353–365.
6. Shah AA, Hasan F, Ahmed S, Hameed A. Extendedspectrum beta-lactamases (ESbLs): characterization, epidemiology and detection. Crit Rev Microbiol. 2004;30(1):25–32.
7. Bush K, Jacoby GA. Updated functional classification of beta-lactamases. Antimicrob Agents Chemother. 2010;54(3):969–976. doi: 10.1128/AAC.01009-09.
8. Paterson DL, Bonomo RA. Clinical Update Extended-Spectrum β-Lactamases : a Clinical Update. Clin Microbiol Rev. 2005;18(4):657–686. doi: 10.1128/CMR.18.4.657-686.2005.
9. Pfaller MA, Segreti J. Overview of the Epidemiological Profile and Laboratory Detection of Extended- Spectrum b -Lactamases. Clin Infect Dis. 2006;42(Suppl 4):S153–S163.
10. Tacão M, Moura A, Correia A, Henriques I. Coresistance to different classes of antibiotics among ESBL-producers from aquatic systems. Water Res. 2014;48:100–107. doi: 10.1016/j.watres.2013.09.021.
11. Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001;14(4):933–951.
12. Cantón R, Akóva M, Carmeli Y, Giske CG, Glupczynski Y, Gniadkowski M, et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect. 2012;18(5):413–431. doi: 10.1111/j.1469-0691.2012.03821.
13. Cockerill FR, Wikler MA, Alder J, Dudley MN, Eliopoulos GM, Ferraro MJ, et al., Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement: Clinical and Laboratory Standards Institute, (CLSI) (pp. M100–S21). Wayne, PA, (USA); Clinical and Laboratory Standards Institute: 2013 [cited 2014 Sep 11]. Available from http://antimicrobianos.com.ar/ATB/wp-content/uploads/2012/11/M100S22E.pdf.
14. Mathers AJ, Hazen KC, Carroll J, Yeh AJ, Cox HL, Bonomo RA, et al. First clinical cases of OXA- 48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the “menace” arrives in the new world. J Clin Microbiol. 2013;51(2):680–683. doi: 10.1128/JCM.02580-12.
15. Wiegand I, Geiss HK, Mack D, Stürenburg E, Seifert H. Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures. J Clin Microbiol. 2007;45(4):1167–1174.
16. Al-Marzooq F, Mohd Yusof MY, Tay ST. Molecular Analysis of Antibiotic Resistance Determinants and Plasmids in Malaysian Isolates of Multidrug Resistant Klebsiella pneumoniae. PLoS One.2015;23(10):e0133654. doi: 10.1371/journal.pone.0133654.
17. Norazah A. National Surveillance of Antibiotic Resistance Report (NSAR), Malaysia: Ministry of Health Malaysia; 2014 [cited 2015 September 1]. http://www.imr.gov.my/images/uploads/NSAR/NSAR_2014/Summary_of_Antibiotic_Resistance:2014_report.pdf.
18. Hawkey PM. Prevalence and clonality of extendedspectrum b-lactamases in Asia. Clin Microbiol Infect. 2008;14(Suppl 1): 159–165.
19. Jean SS, Hsueh PR. High burden of antimicrobial resistance in Asia. Int J Antimicrob Agents. 2011;37(4):291–295. doi: 10.1016/j.ijantimicag.2011.01.009.
20. Garza-González E, Mendoza Ibarra SI, Llaca-Díaz JM, Gonzalez GM. Molecular characterization and antimicrobial susceptibility of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae isolates at a tertiary-care centre in Monterrey, Mexico. J Med Microbiol. 2011;60(Pt1):84–90. doi: 10.1099/jmm.0.022970-0.
21. Sheng WH, Badal RE, Hsueh PR, SMART Program. Causing Intra-Abdominal Infections in the Asia- Pacific Region : Results of the Study for Monitoring Antimicrobial Resistance Trends. Antimicrob Agents Chemother. 2013;57(7):2981–2988. doi: 10.1128/AAC.00971-12.
22. Tissera S, Lee SM. Isolation of Extended Spectrum β-lactamase (ESBL) Producing Bacteria from Urban Surface Waters in Malaysia. Malays J Med Sci. 2013;20(3):14–22.
23. Alhetar KYA, Sekawi Z, Mariana NS, Neela, V. Molecular characterization of extended-spectrum beta-lactimase (ESBL) producing extra-intestinal pathogenic Escherichia coli. African J Microbiol Res. 2001;5(31):5662–5668. doi: 10.5897/AJMR11.836
24. Lim KT, Yeo CC, Yasin RM, Balan G, Thong KL. Characterization of multidrug-resistant and extendedspectrum beta-lactamase-producing Klebsiella pneumoniae strains from Malaysian hospitals. J Med Microbiol. 2009;58(Pt11):1463–1469. doi: 10.1099/jmm.0.011114-0.
25. Sharma J, Sharma M, Ray P. Detection of TEM & SHV genes in Escherichia coli & Klebsiella pneumoniae isolates in a tertiary care hospital from India. Indian J Med Res. 2010;132:332–336.
26. Apisarnthanarak A, Kiratisin P, Mundy LM. Clinical and molecular epidemiology of healthcare-associated infections due to extended-spectrum beta-lactamase (ESBL)-producing strains of Escherichia coli and Klebsiella pneumoniae that harbor multiple ESBL genes. Infect Control Hosp Epidemiol. 2008;29(11):1026–1034. doi: 10.1086/591864.